Literature DB >> 8363188

Methods for Voluntary Weight Loss and Control. Proceedings of NIH Technology Assessment Conference. Bethesda, Maryland, 30 March-1 April 1992.

.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8363188

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

1.  Laparoscopic Roux-en-Y gastric bypass, but not rebanding, should be proposed as rescue procedure for patients with failed laparoscopic gastric banding.

Authors:  Markus Weber; Markus K Müller; Jean-Marie Michel; Rahim Belal; Fritz Horber; Renward Hauser; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2003-12       Impact factor: 12.969

2.  Male gender is a predictor of morbidity and age a predictor of mortality for patients undergoing gastric bypass surgery.

Authors:  Edward H Livingston; Sergio Huerta; Denice Arthur; Scott Lee; Scott De Shields; David Heber
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

3.  Long-term results and gastroesophageal reflux in a series of laparoscopic adjustable gastric banding.

Authors:  Christian A Gutschow; Peter Collet; Klaus Prenzel; Arnulf H Hölscher; Paul M Schneider
Journal:  J Gastrointest Surg       Date:  2005 Sep-Oct       Impact factor: 3.452

4.  Sustained weight loss and improvement of quality of life after laparoscopic adjustable gastric banding for morbid obesity: a single surgeon experience in Ireland.

Authors:  K H Chang; E T Condon; E J O'Connor; O J McAnena
Journal:  Ir J Med Sci       Date:  2009-09-11       Impact factor: 1.568

5.  Cost-Effectiveness Analysis of Bariatric Surgery for Morbid Obesity.

Authors:  Adnan Alsumali; Tewodros Eguale; Sigrid Bairdain; Mihail Samnaliev
Journal:  Obes Surg       Date:  2018-08       Impact factor: 4.129

6.  Revisional weight loss surgery after failed laparoscopic gastric banding: an institutional experience.

Authors:  Tung T Tran; Eric Pauli; Jerome R Lyn-Sue; Randy Haluck; Ann M Rogers
Journal:  Surg Endosc       Date:  2013-07-12       Impact factor: 4.584
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.